{"id":"NCT02497287","sponsor":"Janssen Research & Development, LLC","briefTitle":"A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression","officialTitle":"An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-09-30","primaryCompletion":"2017-10-28","completion":"2017-10-28","firstPosted":"2015-07-14","resultsPosted":"2019-04-29","lastUpdate":"2025-04-29"},"enrollment":802,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Treatment-resistant Depression"],"interventions":[{"type":"DRUG","name":"Esketamine (Intranasal Spray)","otherNames":[]},{"type":"DRUG","name":"Duloxetine (Oral Antidepressant)","otherNames":[]},{"type":"DRUG","name":"Escitalopram (Oral Antidepressant)","otherNames":[]},{"type":"DRUG","name":"Sertraline (Oral Antidepressant)","otherNames":[]},{"type":"DRUG","name":"Venlafaxine Extended Release (XR) (Oral Antidepressant)","otherNames":[]}],"arms":[{"label":"Intranasal Esketamine plus oral antidepressant","type":"EXPERIMENTAL"}],"summary":"The purpose of this open-label, multicenter study is to assess the long term safety and efficacy of intranasal esketamine plus an oral antidepressant in participants with treatment-resistant depression (TRD).","primaryOutcome":{"measure":"Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs)","timeFrame":"Up to End of Follow up Phase (Week 56)","effectByArm":[{"arm":"Intranasal Esketamine + Oral Antidepressant","deltaMin":90.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":109,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Bulgaria","Finland","France","Germany","Lithuania","Malaysia","Mexico","Poland","South Africa","South Korea","Spain","Sweden","Taiwan","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["39435126","38025433","38025416","36525338","36149841","34750057","32316080","32270176"],"seeAlso":["https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217051&amp;parentIdentifier=CR107148&amp;attachmentIdentifier=784eff25-9637-4962-8853-2319a9034a25&amp;fileName=ESKETINTRD3004_(CR107148)_Additional_results_data_CH.pdf&amp;versionIdentifier="]},"adverseEventsSummary":{"seriousAny":{"events":17,"n":779},"commonTop":["Dizziness","Dissociation","Headache","Nausea","Somnolence"]}}